Favorable Results From Dermacyte® Matrix Research Study

RESEARCH TRIANGLE PARK, N.C., March 12, 2024 (GLOBE NEWSWIRE) -- A recent multicenter study has demonstrated encouraging effectiveness and safety of Merakris Therapeutics’ Dermacyte® Amniotic Wound Care Matrix in treating

Related Keywords

Miami , Florida , United States , Otter Creek , Bryant Haskins , Chris Broderick , Otter Creek Communications , Research Triangle Merakris Therapeutics , , Merakris Therapeutic Dermacyte , Amniotic Wound Care Matrix , Dermacyte Matrix , Wound Care , Cellular Acellular , Matrix Like Products , Wound Care Summit , Triangle Park Headquartered Merakris Therapeutics , Amniotic Wound Care Liquid , Merakri Investigational New Drug , Serum Tears , Private Securities Litigation Reform Act , Nation World , Region ,